HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

2,4- diamino- 6- (pyridine- 4- yl)- 1,3,5- triazine

structure in first source

Also Known As:

4PyDAT

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Triazines: 306
    - 2,4-diamino-6-(pyridine-4-yl)-1,3,5-triazine: 1
  - Pyridines: 88
    - 2,4-diamino-6-(pyridine-4-yl)-1,3,5-triazine: 1

Experts

1.	Endo, Y: 1 article (06/2000)
2.	Fujita, H: 1 article (06/2000)
3.	Ligo, M: 1 article (06/2000)
4.	Maeda, M: 1 article (06/2000)
5.	Nakagawa, K: 1 article (06/2000)
6.	Sasaki, T: 1 article (06/2000)
7.	Tsuda, H: 1 article (06/2000)
8.	Yonemura, Y: 1 article (06/2000)

Related Diseases

1.	Neoplasms (Cancer) 06/01/2000 - "These results suggest that the antimetastatic and antitumor activities of 4PyDAT are due in part to inhibition of angiogenesis, rather than direct antiproliferative action on the tumor cells. " 06/01/2000 - "Antimetastatic and antitumor effects of 2,4-diamino-6-(pyridine-4-yl)-1,3,5-triazine (4PyDAT) on the high lung metastatic colon 26 tumor in mice."
2.	Carcinoma (Carcinomatosis) 06/01/2000 - "The therapeutic potential of a diaminotriazine, 2,4-diamino-6-(pyridine-4-yl)-1,3,5-triazine (4PyDAT), was investigated in a metastatic model using the mouse colon 26 carcinoma variant (Co26Lu), which preferentially metastasizes to the lung of mouse. "

Related Drugs and Biologics

1.	2,4- diamino- 6- (pyridine- 4- yl)- 1,3,5- triazine